Overall survival (OS) endpoint: an incomplete evaluation of metastatic breast cancer (MBC) treatment outcome-Reference-Cited by-同舟云学术

Overall survival (OS) endpoint: an incomplete evaluation of metastatic breast cancer (MBC) treatment outcome

Published:2015-03-19 Issue:3 Volume:150 Page:473-478
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Raphael Jacques,Verma S.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-015-3342-2.pdf

Reference35 articles.

1. Ferlay J, Soerjomataram I, Ervik M et al. (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. Available from http://globocan.iarc.fr . Accessed 13 Dec 2013

2. Canadian Cancer Society’s Advisory Committee on Cancer Statistics (2013) Canadian cancer statistics 2013. Canadian Cancer Society, Toronto

3. Chia SK, Speers CH, D’yachkova Y et al (2007) The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer 110(5):973–979

4. Gennari A, Conte P, Rosso R et al (2005) Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies. Cancer 104(8):1742–1750

5. Smith I (2006) Goals of treatment for patients with metastatic breast cancer. Semin Oncol 33(1 Suppl 2):S2–S5

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in endpoint use in pivotal trials and efficacy for US Food and Drug Administration–approved solid tumor therapies, 1995-2021;Journal of Managed Care & Specialty Pharmacy;2022-11

2. Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring;ESMO Open;2021-06

3. Aidi Injection as Adjuvant Drug Combined with Chemotherapy in Treatment of Breast Cancer: A Systematic Meta-Analysis;Evidence-Based Complementary and Alternative Medicine;2021-01-08

4. Visualization of Sequential Treatments in Metastatic Breast Cancer;JCO Clinical Cancer Informatics;2020-09

5. The Evolution of Clinical Trials in Metastatic Breast Cancer: Design Features and Endpoints That Matter;American Society of Clinical Oncology Educational Book;2020-05